134 related articles for article (PubMed ID: 37418994)
1. Expression pattern of lncRNAs in pituitary adenomas.
Ghafouri-Fard S; Khaledabadi M; Najafi G; Safarzadeh A; Hussen BM; Eslami S; Sharifi G; Taheri M; Dilmaghani NA
Pathol Res Pract; 2023 Aug; 248():154668. PubMed ID: 37418994
[TBL] [Abstract][Full Text] [Related]
2. Expression of cAMP and oxidative phosphorylation-related lncRNAs in non-functioning pituitary adenomas.
Taheri M; Nicknam A; Bagan A; Eslami S; Rakhshan A; Ghafouri-Fard S
J Cell Mol Med; 2023 Dec; 27(24):4195-4201. PubMed ID: 37933082
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of MAPKAPK5-AS1, PXN-AS1 and URB1-AS1 lncRNAs in non-functioning pituitary adenoma.
Taheri M; Safarzadeh A; Bahranian A; Eslami S; Dilmaghani NA; Ghafouri-Fard S; Sharifi G
J Cell Mol Med; 2023 Jun; 27(11):1550-1556. PubMed ID: 37154079
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of PVT1 and NEAT1 lncRNAs in pituitary adenomas.
Ghafouri-Fard S; Abbasi F; Nicknam A; Hussen BM; Eslami S; Akbari Dilmaghani N; Taheri M; Sharifi G
Pathol Res Pract; 2023 Aug; 248():154573. PubMed ID: 37270938
[TBL] [Abstract][Full Text] [Related]
5. A bioinformatics-based approach and expression assay for identification of dysregulated genes in pituitary adenoma.
Jamali E; Hashemnejad MA; Askari A; Shomali H; Eslami S; Akbari Dilmaghani N; Sharifi G; Bahranian A; Ghafouri-Fard S
Pathol Res Pract; 2024 Jan; 253():155006. PubMed ID: 38056134
[TBL] [Abstract][Full Text] [Related]
6. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness.
Yu G; Li C; Xie W; Wang Z; Gao H; Cao L; Hao L; Zhang Y
Oncol Rep; 2017 Aug; 38(2):1140-1148. PubMed ID: 28656268
[TBL] [Abstract][Full Text] [Related]
8. circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1.
Du Q; Hu B; Feng Y; Wang Z; Wang X; Zhu D; Zhu Y; Jiang X; Wang H
J Clin Endocrinol Metab; 2019 Jun; 104(6):2419-2434. PubMed ID: 30721952
[TBL] [Abstract][Full Text] [Related]
9. The role of long non-coding RNA FGD5-AS1 in cancer.
He N; Xiang L; Chen L; Tong H; Wang K; Zhao J; Song F; Yang H; Wei X; Jiao Z
Bioengineered; 2022 Apr; 13(4):11026-11041. PubMed ID: 35475392
[TBL] [Abstract][Full Text] [Related]
10. Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior.
Li Z; Li C; Liu C; Yu S; Zhang Y
Pituitary; 2015 Feb; 18(1):42-7. PubMed ID: 24469926
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA FGD5-AS1 Induced by
Wen Y; Luo F; Zhao L; Su S; Lei W; Liu Y; Shi K; Li Z
Front Cell Infect Microbiol; 2021; 11():701352. PubMed ID: 34568091
[TBL] [Abstract][Full Text] [Related]
12. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
Aichen Z; Kun W; Xiaochun S; Lingling T
Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of PPAR-related lncRNAs in breast cancer.
Ghafouri-Fard S; Nicknam A; Safarzadeh A; Eslami S; Samsami M; Jamali E
Pathol Res Pract; 2023 Nov; 251():154844. PubMed ID: 37820438
[TBL] [Abstract][Full Text] [Related]
14. Expression of lncRNA FGD5-AS1 correlates with poor prognosis in melanoma patients.
Gao Y; Zhu H; Mao Q
J Gene Med; 2020 Dec; 22(12):e3278. PubMed ID: 32997827
[TBL] [Abstract][Full Text] [Related]
15. N
Liu J; Zhang N; Zeng J; Wang T; Shen Y; Ma C; Yang M
Clin Transl Med; 2022 Nov; 12(11):e1107. PubMed ID: 36354136
[TBL] [Abstract][Full Text] [Related]
16. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.
Vieria Neto L; Wildemberg LE; Colli LM; Kasuki L; Marques NV; Moraes AB; Gasparetto EL; Takiya CM; Castro M; Gadelha MR
PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of vimentin and the related lncRNA network in breast cancer.
Mohebi M; Ghafouri-Fard S; Modarressi MH; Dashti S; Zekri A; Kholghi-Oskooei V; Taheri M
Exp Mol Pathol; 2020 Aug; 115():104439. PubMed ID: 32283061
[TBL] [Abstract][Full Text] [Related]
18. Identifying critical protein-coding genes and long non-coding RNAs in non-functioning pituitary adenoma recurrence.
Guo J; Fang Q; Liu Y; Xie W; Zhang Y; Li C
Oncol Lett; 2021 Apr; 21(4):264. PubMed ID: 33664827
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of long non-coding RNA FGD5-AS1 affects the development of ovarian cancer through regulating miR-107/RBBP6 axis.
Zhang W; Shi J; Liu G
Chin J Physiol; 2023; 66(3):171-180. PubMed ID: 37322627
[TBL] [Abstract][Full Text] [Related]
20. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.
Rishi A; Sharma MC; Sarkar C; Jain D; Singh M; Mahapatra AK; Mehta VS; Das TK
Neurol India; 2010; 58(3):418-23. PubMed ID: 20644271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
